Sjoerd M. Lagarde

8.3k total citations · 1 hit paper
164 papers, 4.0k citations indexed

About

Sjoerd M. Lagarde is a scholar working on Surgery, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Sjoerd M. Lagarde has authored 164 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Surgery, 122 papers in Pulmonary and Respiratory Medicine and 23 papers in Oncology. Recurrent topics in Sjoerd M. Lagarde's work include Esophageal Cancer Research and Treatment (108 papers), Gastric Cancer Management and Outcomes (104 papers) and Esophageal and GI Pathology (59 papers). Sjoerd M. Lagarde is often cited by papers focused on Esophageal Cancer Research and Treatment (108 papers), Gastric Cancer Management and Outcomes (104 papers) and Esophageal and GI Pathology (59 papers). Sjoerd M. Lagarde collaborates with scholars based in Netherlands, United States and United Kingdom. Sjoerd M. Lagarde's co-authors include J. Jan B. van Lanschot, Olivier R. Busch, Fiebo J.W. ten Kate, Bart A. van Wagensveld, Johannes B. Reitsma, Mark I. van Berge Henegouwen, Usha K. Coblijn, H. Obertop, Jikke M.T. Omloo and Hugo W. Tilanus and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Sjoerd M. Lagarde

154 papers receiving 4.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus

2007 497 citations Sjoerd M. Lagarde, J. Jan B. van Lanschot et al. profile →

Peers

Countries citing papers authored by Sjoerd M. Lagarde

Since Specialization

Citations

This map shows the geographic impact of Sjoerd M. Lagarde's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sjoerd M. Lagarde with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sjoerd M. Lagarde more than expected).

Fields of papers citing papers by Sjoerd M. Lagarde

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sjoerd M. Lagarde. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sjoerd M. Lagarde. The network helps show where Sjoerd M. Lagarde may publish in the future.

Co-authorship network of co-authors of Sjoerd M. Lagarde

This figure shows the co-authorship network connecting the top 25 collaborators of Sjoerd M. Lagarde. A scholar is included among the top collaborators of Sjoerd M. Lagarde based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sjoerd M. Lagarde. Sjoerd M. Lagarde is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Accuracy of Predicting Residual Disease and Disease Progression During Active Surveillance for Esophageal Cancer 2025 ·Annals of Surgical Oncology ·(unknown), David van Klaveren, Sjoerd M. Lagarde, Hester F. Lingsma, Bianca Mostert, Peter‐Paul L. O. Coene, Jan Willem T. Dekker, Henk H. Hartgrink, Joos Heisterkamp, Merlijn Hutteman, Ewout A. Kouwenhoven, Grard A. P. Nieuwenhuijzen, (unknown), Johanna W. van Sandick, Meindert N. Sosef, Edwin S. van der Zaag, J. Jan B. van Lanschot, Bas P. L. Wijnhoven, (unknown)	0
2	252. ACCURACY OF PREDICTING RESIDUAL DISEASE AND DISEASE PROGRESSION DURING ACTIVE SURVEILLANCE FOR ESOPHAGEAL CANCER 2025 ·Diseases of the Esophagus ·(unknown), David van Klaveren, Sjoerd M. Lagarde, Hester F. Lingsma, Bianca Mostert, Camiel Rosman, (unknown), Jan Willem T. Dekker, Henk H. Hartgrink, Joos Heisterkamp, Ewout A. Kouwenhoven, Grard A. P. Nieuwenhuijzen, (unknown), Johanna van Sandick, Meindert N. Sosef, Edwin van der Zaag, Jan van Lanschot, Bas P. L. Wijnhoven	0
3	Oesophagectomy in the East versus the West: comparison of two national audit databases 2025 ·British journal of surgery ·Satoru Matsuda, (unknown), Hiraku Kumamaru, B. Feike Kingma, Hirofumi Kawakubo, Jelle P. Ruurda, Masayuki Watanabe, Hiroaki Miyata, Sjoerd M. Lagarde, (unknown), Richard van Hillegersberg, Ken Shirabe, Bas P. L. Wijnhoven, Yuko Kitagawa	2
4	The prognostic value of peritoneal metastases in patients with gastric cancer: a nationwide population-based study 2025 ·EClinicalMedicine ·(unknown), (unknown), Bo Jan Noordman, H. de Graaf, Irene E.G. van Hellemond, Pieter C. van der Sluis, Esther Oomen‐de Hoop, Sjoerd M. Lagarde, Rob H.A. Verhoeven, Stijn L.W. Koolen, Misha Luyer, Ignace H. J. T. de Hingh, Hanneke W.M. van Laarhoven, Bianca Mostert, Bas P. L. Wijnhoven, Ron H.J. Mathijssen	1
5	Adjuvant Therapy for Patients with a Tumor-Positive Resection Margin After Neoadjuvant Chemoradiotherapy and Esophagectomy 2024 ·Annals of Surgical Oncology ·(unknown), Pieter C. van der Sluis, Bianca Mostert, Joost J. Nuyttens, Manon C.W. Spaander, Roelf Valkema, Jelle P. Ruurda, Bas P. L. Wijnhoven, Sjoerd M. Lagarde	1
6	Risk factors for readmission following esophagectomy and gastrectomy for cancer 2024 ·Diseases of the Esophagus ·(unknown), (unknown), (unknown), Sjoerd M. Lagarde, Bas P. L. Wijnhoven	2
7	Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma in Eastern versus Western countries: meta-analysis 2024 ·British journal of surgery ·Xing Gao, (unknown), Ben M. Eyck, (unknown), Daan Nieboer, Pieter C. van der Sluis, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, Yin‐Kai Chao, J. Jan B. van Lanschot	1
8	The effectiveness of neoadjuvant chemoradiotherapy in oesophageal adenocarcinoma with presence of extracellular mucin, signet‐ring cells, and/or poorly cohesive cells 2023 ·The Journal of Pathology Clinical Research ·(unknown), (unknown), Rachel S. van der Post, Ariadne H.A.G. Ooms, Lindsey Oudijk, Ben M. Eyck, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, Bastiaan Klarenbeek, Camiel Rosman, J. Jan B. van Lanschot, Michail Doukas	2
9	Long-Term Survival Associated with Direct Oral Feeding Following Minimally Invasive Esophagectomy: Results from a Randomized Controlled Trial (NUTRIENT II) 2023 ·Cancers ·(unknown), Teus J. Weijs, Gijs H. K. Berkelmans, Laura F. C. Fransen, Ewout A. Kouwenhoven, Marc J. van Det, Magnus Nilsson, Sjoerd M. Lagarde, Richard van Hillegersberg, Sheraz R. Markar, Grard A. P. Nieuwenhuijzen, Misha Luyer	3
10	Surgeon's steering behaviour towards patients to participate in a cluster randomised trial on active surveillance for oesophageal cancer: A qualitative study 2023 ·European Journal of Surgical Oncology ·(unknown), (unknown), (unknown), Berend J. van der Wilk, Bas P. L. Wijnhoven, Anne M. Stiggelbout, Jan Willem T. Dekker, Peter Paul L. O. Coene, Jan J.V. Busschbach, J. Jan B. van Lanschot, Sjoerd M. Lagarde, Leonieke W. Kranenburg	1
11	Survival trends of patients with non‐metastatic gastric adenocarcinoma in the US and European countries: the impact of decreasing resection rates 2022 ·Cancer Communications ·Lei Huang, Lina Jansen, Rob H.A. Verhoeven, Jelle P. Ruurda, Liesbet Van Eycken, Harlinde De Schutter, Jan Johansson, Mats Lindblad, T.B. Johannesen, Vesna Zadnik, Tina Žagar, Sjoerd M. Lagarde, Cornelis J.�H. van de Velde, Petra Schrotz‐King, Hermann Brenner	15
12	Liver oligometastatic disease in synchronous metastatic gastric cancer patients: a nationwide population-based cohort study 2022 ·European Journal of Cancer ·Tiuri E. Kroese, Yuko Takahashi, Florian Lordick, Peter S.N. van Rossum, Jelle P. Ruurda, Sjoerd M. Lagarde, Richard van Hillegersberg, Rob H.A. Verhoeven, Hanneke W.M. van Laarhoven	6
13	Population-based study of treatment and outcome of recurrent oesophageal or junctional cancer 2022 ·British journal of surgery ·(unknown), Pauline A. J. Vissers, David Bertwistle, Laura McDonald, Laurens V. Beerepoot, Mark I. van Berge Henegouwen, Sjoerd M. Lagarde, Stella Mook, Nadia Haj Mohammad, Paul M. Jeene, Hanneke W.M. van Laarhoven, Rob H.A. Verhoeven	3
14	Pathological response to neoadjuvant chemoradiotherapy for oesophageal squamous cell carcinoma: multicentre East Asian and Dutch database comparison 2022 ·British journal of surgery ·Ben M. Eyck, Xing Gao, Yang Yang, Berend J. van der Wilk, Yhi Wong, Bas P. L. Wijnhoven, Jun Liu, Sjoerd M. Lagarde, (unknown), Maarten C.C.M. Hulshof, Zhigang Li, Simon Law, Yin‐Kai Chao, J. Jan B. van Lanschot, (unknown), (unknown)	11
15	Preferences for active surveillance or standard oesophagectomy: discrete-choice experiment 2021 ·British journal of surgery ·Berend J. van der Wilk, Inge Spronk, Bo Jan Noordman, Ben M. Eyck, Juanita A. Haagsma, Peter‐Paul L. O. Coene, Erwin van der Harst, Joos Heisterkamp, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, J. Jan B. van Lanschot	2
16	Pattern of recurrence in patients with a pathologically complete response after neoadjuvant chemoradiotherapy and surgery for oesophageal cancer 2021 ·BJS Open ·(unknown), Ben M. Eyck, Leonie R. van der Werf, (unknown), J. Jan B. van Lanschot, Sjoerd M. Lagarde, Ate van der Gaast, Joost J. Nuyttens, Bas P. L. Wijnhoven	12
17	Transthoracic esophagectomy compared to transhiatal extended gastrectomy for adenocarcinoma of the esophagogastric junction: a multicenter retrospective cohort study 2021 ·Diseases of the Esophagus ·Carlo Alberto De Pasqual, Pieter C. van der Sluis, Jacopo Weindelmayer, Sjoerd M. Lagarde, Simone Giacopuzzi, Giovanni De Manzoni, Bas P. L. Wijnhoven	3
18	Lasting symptoms and long-term health-related quality of life after totally minimally invasive, hybrid and open Ivor Lewis esophagectomy 2021 ·European Journal of Surgical Oncology ·Ben M. Eyck, Fredrik Klevebro, Berend J. van der Wilk, Asif Johar, Bas P. L. Wijnhoven, J. Jan B. van Lanschot, Pernilla Lagergren, Sheraz R. Markar, Sjoerd M. Lagarde	9
19	Residual disease after neoadjuvant chemoradiotherapy for oesophageal cancer: locations undetected by endoscopic biopsies in the preSANO trial 2020 ·British journal of surgery ·Berend J. van der Wilk, Ben M. Eyck, Michail Doukas, Manon C.W. Spaander, Erik J. Schoon, Kausilia K. Krishnadath, Liekele E. Oostenbrug, Sjoerd M. Lagarde, B.P.L. Wijnhoven, Leendert H. J. Looijenga, Katharina Biermann, J.J.B. van Lanschot	11
20	The Impact of Signet Ring Cell Differentiation on Outcome in Patients with Esophageal and Gastroesophageal Junction Adenocarcinoma 2019 ·Annals of Surgical Oncology ·(unknown), B. Mark Smithers, D. C. Gotley, Sandra Brosda, Iain Thomson, Janine Thomas, Michael G. Gartside, J. Jan B. van Lanschot, Sjoerd M. Lagarde, Bas P. L. Wijnhoven, Andrew P. Barbour	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact